Potential drawbacks of pharmacy-based COVID-19 testing

Lippi, G.; Henry, B. M.; Plebani, M.

Lippi, G.; Henry, B. M.; Plebani, M..

Journal of Laboratory and Precision Medicine ; 6(April) (no pagination), 2021.

Artigo em Inglês | EMBASE | ID: covidwho-2269214

Palavras-chave

asymptomatic coronavirus disease 2019, clinical laboratory, coronavirus disease 2019/di [Diagnosis], cost effectiveness analysis, COVID-19 testing, diagnostic accuracy, editorial, false negative result, health care personnel, human, infection prevention, laboratory test, managed care, mass screening, nasopharyngeal swab, pandemic, patient counseling, pharmacy (shop), point of care testing, priority journal, quality control, sensitivity and specificity, Severe acute respiratory syndrome coronavirus 2, virus load, virus transmission, tracer

Texto completo

Imprimir

XML

Buscar no Google

Texto completo: Disponível Coleções: Bases de dados de organismos internacionais Base de dados: EMBASE Idioma: Inglês Revista: Journal of Laboratory and Precision Medicine Ano de publicação: 2021 Tipo de documento: Artigo

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

Buscar no Google